Viral Hepatitis is a group of infectious diseases that affect the liver and can lead to severe health complications if left untreated. It is caused by different viruses, including hepatitis A, B, C, D, and E. Each type varies in transmission routes and severity of symptoms. Hepatitis A is typically contracted through contaminated food or water, while hepatitis B and C spread through contact with infected blood or body fluids such as during unprotected sex or sharing needles. Hepatitis D occurs only in individuals already infected with hepatitis B, whereas hepatitis E is usually transmitted through consuming contaminated water or undercooked meat. Symptoms may range from mild fatigue to jaundice (yellowing of the skin and eyes), dark urine, abdominal pain, nausea/vomiting, and loss of appetite. Although some people might remain asymptomatic for years after infection with viral hepatitis types B and C known as chronic infections - it can eventually cause cirrhosis (scarring) of the liver leading to organ failure or hepatocellular carcinoma (liver cancer). Early diagnosis through blood tests allows for treatments aiming at suppressing virus replication successfully; however, vaccination remains the most effective prevention method against this global health concern
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
Patients value communication skills from cancer surgeons across six key areas, according to research
3.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
4.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
5.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
1.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
2.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
3.
Iron Deficiency Anemia: Challenges in Diagnosis and Treatment
4.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
5.
The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation